Enzymotec Ltd. Granted U.S. Patent for INFAT to Promote Intestinal Development and Maturation

By: via Benzinga
Enzymotec Ltd., (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.